+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cryopreservation Bags and Freezing Bags Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6102943
The global cryopreservation bags and freezing bags market was valued at USD 125.47 Million in 2024, driven by rising demand for cryopreservation bags and technological advancements across the globe. The market is anticipated to grow at a CAGR of 8.00% during the forecast period of 2025-2034, with the values likely to reach USD 270.88 Million by 2034.

Cryopreservation Bags and Freezing Bags Market Overview

Cryopreservation bags are specialized containers in which biological materials can be stored at very low temperatures. These ensure the preservation of cell structures and other components. Freezing bags have similar purposes in the safe storage of biological samples, vaccines, and pharmaceuticals. These bags are made to store biological samples under ultra-low temperatures such as blood, plasma, and stem cells. The growing market demand is due to the rising application of cryopreservation bags and freezing bags in the healthcare and biotechnology sectors. Further, the market is driven by advancements in regenerative medicine, the growing demand for biopharmaceuticals, and growth in clinical trial activity.

Cryopreservation Bags and Freezing Bags Market Growth Drivers

Rising Demand for Cryopreservation Bags to Boost the Market Demand

The rising demand for cryopreservation bags in research, diagnostics, and treatment development is driving the growth of the market across the globe. Biobanks are becoming important as they store biological samples, such as blood, tissues, and stem cells, that require efficient long-term preservation methods. Cryopreservation bags are safe and cost-effective solutions for the ultra-low temperature storage of biological materials. As more research institutes and healthcare providers establish biobanks, there is increased demand for reliable cryopreservation solutions.

Technological Advancements in Cryopreservation Methods to Elevate the Market Value

Cryopreservation technology advancements are boosting market growth due to the improving efficiency and safety of freezing bags. Innovative designs enhance the preservation of cells and tissues, maintaining the integrity of cells and tissues during the freeze-thaw cycle. Such efficient and cost-effective solutions are increasing adoption by the medical, research, and pharmaceutical sectors, creating further demand for advanced cryopreservation bags.

Cryopreservation Bags and Freezing Bags Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Shift Toward Single-Use Cryopreservation Bags

A notable trend in the market is the growing shift towards single-use cryopreservation bags. These bags are in high demand for the storage and transportation of biological samples, offering a sterile and contamination-free environment. Moreover, they are favored for their convenience, cost-effectiveness, and enhanced safety compared to reusable alternatives.

Adoption of Automated Cryopreservation Systems

Automation in cryopreservation is another significant trend in the market. Automated systems facilitate handling biological samples quickly and accurately while ensuring consistent storage conditions free from human error. Automation of processes with cryopreservation bags will enhance efficiency, reduce human input, and eventually reduce risks during the storage and thawing process.

Growing Preference for Biodegradable and Sustainable Packaging

The market is increasingly shifting toward sustainability, along with mounting demand for biodegradable and eco-friendly packaging solutions. Environmental concerns are rising at a pivotal rate. Many manufacturers are trying to concentrate on developing cryopreservation bags made from sustainable materials. To reduce the use of plastics and enhance the environmental footprint of the healthcare and biotechnology industries, the trend is set to encourage sustainable solutions.

Expansion of Biobanking Activities

Biobanks, which store biological specimens for research, diagnostics, and therapeutic applications, are expanding globally. The increased interest in personalized medicine and genomics is driving the need for long-term preservation of DNA, RNA, and other biological samples. Cryopreservation bags are preferred over traditional storage containers in biobanks due to their cost-effectiveness, flexibility, and superior sample protection.

Cryopreservation Bags and Freezing Bags Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Type of Analyte

  • Blood
  • Biologics
  • Tissue

Market Breakup by End User

  • Blood Bank
  • Bio-Pharmaceutical Companies
  • Ambulatory Surgical Facility
  • Hospital
  • Academic and Research Institute
  • Other

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Cryopreservation Bags and Freezing Bags Market Share

Segmentation Based on End User to Witness Substantial Growth

Based on the end user, the market is divided into blood banks, bio-pharmaceutical companies, ambulatory surgical facilities, hospitals, academic and research institutes, and others. Blood banks have a prominent market share in cryopreservation bags and freezing bags globally. The increased demand for blood storage, especially in transfusion-demanding regions, makes blood banks a key market segment. Additionally, the growing volume of blood donations and the need for effective long-term preservation drive this segment's growth in cryopreservation technology.

Cryopreservation Bags and Freezing Bags Market Analysis by Region

The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds a significant share in the global cryopreservation bags and freezing bags market. The region is characterized by a well-developed healthcare infrastructure and robust pharmaceutical and biotechnology industries along with an increasing number of clinical trials. The United States is particularly strong in innovation and funding for research, leading to the potential for higher demand in cryopreservation solutions, not only from blood banks but also from academic institutions and biopharma companies.

Leading Players in the Cryopreservation Bags and Freezing Bags Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

American Durafilm Co., Inc.

American Durafilm Co., Inc. was established in 1976 and is headquartered in Holliston, Massachusetts. Their key products include Kapton polyimide cryogenic bags, which are perfect for tissue and cell preservation. Superior liquid nitrogen resistance makes these bags ideal for maintaining the integrity of biological samples stored in cryogenic storage over the long term.

OriGen Biomedical

OriGen Biomedical, established in 2005, in Austin, Texas, specializes in cryopreservation and freezing bags. Its flagship products comprise the CryoStore Freezing Bag, CryoStore 25 Freezing Bag, and CryoStore Flex Bag, which are applicable for freezing blood components. These products focus on user-friendliness, stability, and improvement of patient care.

CellBios Healthcare & Lifesciences Pvt. Ltd

CellBios, an Indian headquartered company, is involved in innovative cryopreservation solutions for biomedical applications. Their flagship product, CellStor® Freezing Bags, allows blood, stem cells, and tissues to be cryopreserved down to -196°C in over 50 different configurations. They ensure safe storage and thawing for cell/gene therapy, bioprocessing, and tissue preservation.

Charter Medical Corporation

Charter Medical is a single-use cryopreservation solution provider for critical materials. It was established in 1997, and headquartered in Winston-Salem, North Carolina. The company's leading products in the global cryopreservation and freezing bags market are Cell Freeze® Cryogenic Containers, Freeze-Pak™ Bio-Containers, and Freeze-Pak™ with FP-FLEX™ Tubing, designed to ensure safe storage, transport, and preservation of cell and gene therapies.

Other key players in the market include Instant Systems, Inc., Macopharma Pvt Ltd, OriGen Biomedical Inc., Sartorius Aktiengesellschaft, and Shandong Weigao Group Co. Ltd.

Key Questions Answered in the Cryopreservation Bags and Freezing Bags Market Report

  • What was the cryopreservation bags and freezing bags market value in 2024?
  • What are the cryopreservation bags and freezing bags market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is the market segmentation based on the type of analyte?
  • What is the market breakup based on the end user?
  • What major factors aid the cryopreservation bags and freezing bags market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the major drivers, opportunities, and restraints in the market?
  • What are the major trends influencing the market?
  • Which regional market is expected to dominate the market share in the forecast period?
  • Which country is likely to experience elevated growth during the forecast period?
  • Who are the key players involved in the cryopreservation bags and freezing bags market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cryopreservation Bags and Freezing Bags Market Overview
3.1 Global Cryopreservation Bags and Freezing Bags Market Historical Value (2018-2024)
3.2 Global Cryopreservation Bags and Freezing Bags Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Cryopreservation Bags and Freezing Bags Market Landscape*
5.1 Global Cryopreservation Bags and Freezing Bags Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Cryopreservation Bags and Freezing Bags Market: Product Landscape
5.2.1 Analysis by Type of Analyte
6 Global Cryopreservation Bags and Freezing Bags Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Cryopreservation Bags and Freezing Bags Market Segmentation (218-2034)
7.1 Global Cryopreservation Bags and Freezing Bags Market (2018-2034) by Type of Analyte
7.1.1 Market Overview
7.1.2 Blood
7.1.3 Biologics
7.1.4 Tissue
7.2 Global Cryopreservation Bags and Freezing Bags Market (2018-2034) by End User
7.2.1 Market Overview
7.2.2 Blood Bank
7.2.3 Bio-Pharmaceutical Companies
7.2.4 Ambulatory Surgical Facility
7.2.5 Hospital
7.2.6 Academic and Research Institute
7.2.7 Other
7.3 Global Cryopreservation Bags and Freezing Bags Market (2018-2034) by Region
7.3.1 Market Overview
7.3.2 North America
7.3.3 Europe
7.3.4 Asia Pacific
7.3.5 Latin America
7.3.6 Middle East and Africa
8 North America Cryopreservation Bags and Freezing Bags Market (218-2034)
8.1 North America Cryopreservation Bags and Freezing Bags Market (2018-2034) by Type of Analyte
8.1.1 Market Overview
8.1.2 Blood
8.1.3 Biologics
8.1.4 Tissue
8.2 North America Cryopreservation Bags and Freezing Bags Market (2018-2034) by End User
8.2.1 Market Overview
8.2.2 Blood Bank
8.2.3 Bio-Pharmaceutical Companies
8.2.4 Ambulatory Surgical Facility
8.2.5 Hospital
8.2.6 Academic and Research Institute
8.2.7 Other
8.3 North America Cryopreservation Bags and Freezing Bags Market (2018-2034) by Country
8.3.1 United States of America
8.3.2 Canada
9 Europe Cryopreservation Bags and Freezing Bags Market (218-2034)
9.1 Europe Cryopreservation Bags and Freezing Bags Market (2018-2034) by Type of Analyte
9.1.1 Market Overview
9.1.2 Blood
9.1.3 Biologics
9.1.4 Tissue
9.2 Europe Cryopreservation Bags and Freezing Bags Market (2018-2034) by End User
9.2.1 Market Overview
9.2.2 Blood Bank
9.2.3 Bio-Pharmaceutical Companies
9.2.4 Ambulatory Surgical Facility
9.2.5 Hospital
9.2.6 Academic and Research Institute
9.2.7 Other
9.3 Europe Cryopreservation Bags and Freezing Bags Market (2018-2034) by Country
9.3.1 United Kingdom
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Others
10 Asia Pacific Cryopreservation Bags and Freezing Bags Market (218-2034)
10.1 Asia Pacific Cryopreservation Bags and Freezing Bags Market (2018-2034) by Type of Analyte
10.1.1 Market Overview
10.1.2 Blood
10.1.3 Biologics
10.1.4 Tissue
10.2 Asia Pacific Cryopreservation Bags and Freezing Bags Market (2018-2034) by End User
10.2.1 Market Overview
10.2.2 Blood Bank
10.2.3 Bio-Pharmaceutical Companies
10.2.4 Ambulatory Surgical Facility
10.2.5 Hospital
10.2.6 Academic and Research Institute
10.2.7 Other
10.3 Asia Pacific Cryopreservation Bags and Freezing Bags Market (2018-2034) by Country
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 ASEAN
10.3.5 Australia
10.3.6 Others
11 Latin America Cryopreservation Bags and Freezing Bags Market (218-2034)
11.1 Latin America Cryopreservation Bags and Freezing Bags Market (2018-2034) by Type of Analyte
11.1.1 Market Overview
11.1.2 Blood
11.1.3 Biologics
11.1.4 Tissue
11.2 Latin America Cryopreservation Bags and Freezing Bags Market (2018-2034) by End User
11.2.1 Market Overview
11.2.2 Blood Bank
11.2.3 Bio-Pharmaceutical Companies
11.2.4 Ambulatory Surgical Facility
11.2.5 Hospital
11.2.6 Academic and Research Institute
11.2.7 Other
11.3 Latin America Cryopreservation Bags and Freezing Bags Market (2018-2034) by Country
11.3.1 Brazil
11.3.2 Argentina
11.3.3 Mexico
11.3.4 Others
12 Middle East and Africa Cryopreservation Bags and Freezing Bags Market (218-2034)
12.1 Middle East and Africa Cryopreservation Bags and Freezing Bags Market (2018-2034) by Type of Analyte
12.1.1 Market Overview
12.1.2 Blood
12.1.3 Biologics
12.1.4 Tissue
12.2 Middle East and Africa Cryopreservation Bags and Freezing Bags Market (2018-2034) by End User
12.2.1 Market Overview
12.2.2 Blood Bank
12.2.3 Bio-Pharmaceutical Companies
12.2.4 Ambulatory Surgical Facility
12.2.5 Hospital
12.2.6 Academic and Research Institute
12.2.7 Other
12.3 Middle East and Africa Cryopreservation Bags and Freezing Bags Market (2018-2034) by Country
12.3.1 Saudi Arabia
12.3.2 United Arab Emirates
12.3.3 Nigeria
12.3.4 South Africa
12.3.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Drug Class of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Drug Class of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 American Durafilm Co., Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Development
17.2.5 Certifications
17.3 OriGen Biomedical
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Development
17.3.5 Certifications
17.4 CellBios Healthcare & Lifesciences Pvt. Ltd
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Development
17.4.5 Certifications
17.5 Charter Medical Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Development
17.5.5 Certifications
17.6 Instant Systems, Inc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Development
17.6.5 Certifications
17.7 Macopharma Pvt Ltd
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Development
17.7.5 Certifications
17.8 OriGen Biomedical Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Development
17.8.5 Certifications
17.9 Sartorius Aktiengesellschaft
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Development
17.9.5 Certifications
17.10 Shandong Weigao Group Co. Ltd
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Development
17.10.5 Certifications
18 Global Cryopreservation Bags and Freezing Bags Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • American Durafilm Co., Inc.
  • OriGen Biomedical
  • CellBios Healthcare & Lifesciences Pvt. Ltd
  • Charter Medical Corporation

Table Information